Delivery Order SPE2DB20D1004-SPE2DB23FF7N3

Award Date 4/26/23
Potential Completion Date 4/27/23
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $46,045.62, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with a completion date of December 19, 2024. The contract is a Delivery Order (DO) under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical,...
This federal contract award, valued at $10,121.82, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through January 17, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $6,645.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support military healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $3,750.09, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,798.59, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a completion date of November 28, 2023. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
The federal contract award, valued at $1,307.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, and has an ultimate completion date of January 6, 2025. This contract award is not designated as a set-aside and is a delivery order contract with a firm fixed price pricing type. AmerisourceBergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $49,995.00, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, to support military healthcare programs. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,993.56, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of August 5, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type, and it is not designated with a set-aside requirement. Amerisourcebergen holds...
This federal contract award, valued at $71,357.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, which is a Delivery Order, covers the supply of TRELEGY ELLIPTA 200-62.5-25 60S, a prescription medication, to support military healthcare programs. The contract has an ultimate completion date of November 15, 2024 and is a Firm Fixed Price contract type. This award is part of a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract, valued at $2,031.49, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB23FF7N3
    Delivery Order

This federal contract award, valued at $1,147.08, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 200-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of April 27, 2023.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/9/25, 9:53 AM